Page 1 of Clinical Trials for Vertex Pharmaceuticals Incorporated [SPONSOR-COLLABORATORS], 71 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 HCV
Last Updated: June 22, 2011
Condition(s): Hepatitis C
2
Completed
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Last Updated: June 22, 2011
Condition(s): Hepatitis C
3
Completed
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Last Updated: March 22, 2012
Condition(s): Hepatitis C; HIV Infections
4
Completed
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
Last Updated: April 6, 2010
Condition(s): Hepatitis C
5
Active, not recruiting
Virology Follow up Study in Subjects Previously Treated With Telaprevir
Last Updated: September 28, 2011
Condition(s): Hepatitis C
6
Completed
Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
Last Updated: January 2, 2010
Condition(s): Cystic Fibrosis
7
Completed
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Last Updated: December 17, 2007
Condition(s): Hepatitis C; Hepatitis
8
Completed
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
Last Updated: April 13, 2011
Condition(s): Cystic Fibrosis
9
Recruiting
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Last Updated: May 18, 2012
Condition(s): Hepatitis C
10
Active, not recruiting
Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation
Last Updated: September 26, 2011
Condition(s): Cystic Fibrosis
11
Recruiting
A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus
Last Updated: May 18, 2012
Condition(s): Influenza Virus
12
Completed
Study of Telaprevir in Subjects With Hepatic Impairment
Last Updated: October 28, 2008
Condition(s): Hepatic Insufficiency
13
Active, not recruiting
Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation
Last Updated: March 9, 2012
Condition(s): Cystic Fibrosis
14
Active, not recruiting
Study of VX-770 in Cystic Fibrosis Subjects
Last Updated: January 3, 2012
Condition(s): Cystic Fibrosis
15
Recruiting
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Last Updated: May 18, 2012
Condition(s): Hepatitis C, Chronic
16
Recruiting
A Study to Compare the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) to Standard of Care in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Last Updated: May 21, 2012
Condition(s): Chronic Hepatitis C Virus
17
Completed
Safety Study of VX 770 in Subjects With Cystic Fibrosis
Last Updated: October 11, 2010
Condition(s): Cystic Fibrosis
18
Active, not recruiting
A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection
Last Updated: May 18, 2012
Condition(s): Chronic Hepatitis C Virus Infection
19
Completed
Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects
Last Updated: February 18, 2009
Condition(s): Healthy
20
Completed
Study of VX-770 in Cystic Fibrosis Subjects Age 6 to 11 With the G551D Mutation
Last Updated: January 4, 2012
Condition(s): Cystic Fibrosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Vertex+Pharmaceuticals+Incorporated

Page 1 of Clinical Trials for Vertex Pharmaceuticals Incorporated [SPONSOR-COLLABORATORS], 71 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About